Results 141 to 150 of about 4,291 (203)

Tyrosine kinase signaling pathways as therapeutic targets in autoimmune subepidermal blistering skin diseases (pemphigoid diseases). [PDF]

Front Immunol
Vikár S, Mócsai A.
europepmc   +1 more source

The morbidity of systemic steroids: analyzing its use in bullous pemphigoid. [PDF]

An Bras Dermatol
Nieto-Benito LM, Suárez-Fernández R.
europepmc   +1 more source

Pemphigoid Antibodies in Patients with Oral Lichen Planus: A Systematic Review. [PDF]

Pathophysiology
De Falco D, Di Stasio D, Caggiula A, Lajolo C, Lucchese A, Petruzzi M.   +5 more
europepmc   +1 more source

Autoimmune Bullous Diseases: Therapeutic Update. [PDF]

Drugs
Kasperkiewicz M, van Beek N, Schmidt E.
europepmc   +1 more source

Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid. [PDF]

JID Innov
Lytton SD, Wagger C, Meyersburg D, Mussnig B, Lang R, Maglie R, Anzengruber F, Antiga E, Hall RP, Bauer JW.   +9 more
europepmc   +1 more source

Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. [PDF]

Sci Adv
Mai S, Mai Y, Ujiie I, Izumi K, Natsuga K, Nishie W, Ujiie H.   +6 more
europepmc   +1 more source

Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series. [PDF]

J Dtsch Dermatol Ges
Yilmaz K, Goletz S, Hammers CM, Boch K, Zeidler C, Wiegmann H, Bergmann E, Lari TR, Dikmen O, Häring N, Strohal R, Kleinheinz A, Hadaschik EN, van Beek N, Ständer S, Schmidt E.   +15 more
europepmc   +1 more source

Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue <i>COL17A1</i> mutations and dysregulation. [PDF]

JID Innov
Chang RC, Olbrich H, Wang YF, Gainer H, Curkovic N, Walunas TL, Shiu J, Goyal P, Mansini AP, Ludwig RJ, Amber KT.   +10 more
europepmc   +1 more source

A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. [PDF]

Cureus
Palacio I, Arraut K, Portalatin K, Estil-Las AA, Grace M.   +4 more
europepmc   +1 more source

A case of bullous pemphigoid in an ulcerative colitis patient treated with vedolizumab. [PDF]

JAAD Case Rep
Odom MB, Chen JN, Echavarria JF, Gilson RT.   +3 more
europepmc   +1 more source